Neither hypoglycemia nor hyperglycemia is universally “worse” because they threaten the body on fundamentally different timescales. A severe drop in blood sugar can cause brain failure, dangerous heart rhythms, and death within hours. Persistently high blood sugar, by contrast, quietly damages blood vessels and organs over months and years, driving complications like kidney disease, vision loss, and heart attacks. The real clinical picture is shaped by whether you’re asking about the next few hours or the next few decades.
What Happens When Blood Sugar Drops Too Low
The brain runs almost exclusively on glucose. When blood sugar falls, the body mounts a defense in a specific sequence: insulin secretion decreases first, then stress hormones like glucagon and epinephrine kick in. Symptoms such as shakiness, sweating, and confusion appear when glucose drops to about 3.0 mmol/L (roughly 54 mg/dL), and measurable cognitive dysfunction sets in at even lower levels, around 2.6 mmol/L.1Hormone and Metabolic Research. Hierarchy of physiological responses to hypoglycemia: Relevance to clinical hypoglycemia in type I (insulin dependent) diabetes mellitus In a healthy person, this cascade usually corrects itself. In someone taking insulin or certain diabetes medications, the correction can fail, and blood sugar keeps falling.
When it falls far enough, the consequences become immediately life-threatening. Severe hypoglycemia causes what researchers call “functional brain failure,” a state of neurological shutdown that is typically reversible if glucose is restored quickly but can progress to permanent brain damage or death if it is not.2PubMed Central. Hypoglycemia, functional brain failure, and brain death The heart is also at risk. Animal and clinical research has shown that severe hypoglycemia triggers dangerous cardiac arrhythmias, including premature ventricular contractions, rapid heart rates, and heart block, driven by the same sympathetic nervous system surge that is supposed to rescue the body from low glucose.3PubMed Central. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation Seizures add another layer of danger. Research found that blocking arrhythmias alone or seizures alone was not enough to prevent death from severe hypoglycemia; only combined treatment that addressed both heart rhythm disturbances and seizures achieved full survival.4PubMed Central. Severe hypoglycemia-induced sudden death is mediated by both cardiac arrhythmias and seizures
This is why acute hypoglycemia gets the more alarming reputation. A person with dangerously high blood sugar usually has hours or days before reaching a medical crisis. A person with dangerously low blood sugar can lose consciousness or go into cardiac arrest in minutes.
The Slow Destruction of Chronic Hyperglycemia
High blood sugar does not announce itself the way low blood sugar does. You can walk around with a blood glucose of 250 or 300 mg/dL and feel only mildly tired or thirsty. But over time, persistently elevated glucose causes chemical changes in the proteins throughout your body. Sugars attach to proteins and form compounds known as advanced glycation end-products, and these altered proteins accumulate in blood vessel walls, the kidneys, the retina, and nerves. Epidemiological research has confirmed that hyperglycemia is the most important factor in the onset and progression of vascular complications in both type 1 and type 2 diabetes, including nephropathy, retinopathy, neuropathy, and atherosclerosis.5Physiological Research. Advanced glycation end-products and the progress of diabetic vascular complications
The link to cardiovascular disease is especially well documented. Elevated glucose, along with the lipid abnormalities that often accompany it, contributes to atherosclerosis at nearly every stage of plaque formation.6PubMed Central. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation Hyperglycemia triggers cellular changes in blood vessel tissue that directly accelerate arterial narrowing and stiffening.7PubMed Central. How hyperglycemia promotes atherosclerosis: molecular mechanisms The result is that people with poorly controlled diabetes face dramatically higher rates of heart attack and stroke, and these cardiovascular events account for the majority of diabetes-related deaths.
So while hypoglycemia is the more immediately lethal of the two, chronic hyperglycemia is the bigger killer in absolute terms, simply because it damages so many organ systems simultaneously and does so over years.
Acute Hyperglycemia Can Be an Emergency Too
It would be a mistake to think hyperglycemia is only a slow-burn problem. Two acute crises can develop when blood sugar spikes extremely high. Diabetic ketoacidosis occurs primarily in type 1 diabetes when the body has almost no insulin and begins breaking down fat at an unsustainable rate, flooding the blood with acidic ketones. Hyperosmolar hyperglycemic state tends to occur in type 2 diabetes and involves extremely high blood sugar, often above 600 mg/dL, with severe dehydration. Both are life-threatening and significantly increase mortality.8PubMed Central. Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state In these scenarios, hyperglycemia can kill just as quickly as hypoglycemia, though with different mechanisms. The distinction between “hyperglycemia is slow” and “hypoglycemia is fast” is a useful shorthand but not an absolute rule.
Both Extremes Damage the Brain
One area where hypoglycemia and hyperglycemia converge is their effect on the brain. Low blood sugar starves neurons of fuel, which can cause cell degeneration and progressive cognitive decline when episodes are repeated.9PubMed Central. Dementia in Diabetes: The Role of Hypoglycemia A large study of older adults with type 2 diabetes found a graded relationship between hypoglycemic episodes and dementia risk: one episode raised the risk by roughly a quarter, two episodes nearly doubled it, and three or more episodes roughly doubled it again relative to having no episodes at all.10JAMA. Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus
Chronic hyperglycemia damages the brain through different pathways, including the same vascular injury and protein modification it causes elsewhere. Small-vessel disease in the brain driven by high blood sugar increases the risk of vascular dementia and appears to worsen Alzheimer’s pathology. So the brain sits in a lose-lose position: starved of fuel on the low end, chemically battered on the high end. For people managing diabetes, this means that both repeated lows and sustained highs carry long-term cognitive consequences, and avoiding one at the expense of the other is not a safe trade.
The J-Shaped Mortality Curve
Perhaps the most striking evidence that both extremes are dangerous comes from studies looking at long-term average blood sugar, measured by HbA1c, and overall mortality. A meta-analysis of observational studies found a J-shaped relationship between HbA1c and all-cause mortality in people with type 2 diabetes, meaning death rates rise at both high and low ends of the HbA1c range.11PubMed Central. The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies A separate large study put a finer point on the shape: in people with diabetes, the lowest mortality was associated with an HbA1c of about 6.5%, and death rates climbed on either side of that value.12The Journal of Clinical Endocrinology & Metabolism. Glycated Hemoglobin and All-Cause and Cause-Specific Mortality Among Adults With and Without Diabetes
The elevated mortality at the low end of HbA1c is thought to reflect, at least in part, the toll of frequent hypoglycemia among people on aggressive glucose-lowering therapy. The body is not designed to tolerate either extreme, and the data confirm that the safest place is somewhere in the middle.
What the ACCORD Trial Revealed
The tension between controlling hyperglycemia and risking hypoglycemia came into sharp focus in the ACCORD trial, one of the most influential diabetes studies of the past two decades. Researchers assigned high-risk type 2 diabetes patients either to intensive therapy aiming for near-normal blood sugar levels or to standard therapy with more moderate goals. The intensive group did get lower average blood sugar, but they also had significantly more episodes of severe hypoglycemia. After about three and a half years, the intensive group had more deaths than the standard group, prompting the researchers to stop that arm of the trial early.13PubMed. Effects of intensive glucose lowering in type 2 diabetes
The exact mechanism behind the increased mortality is still debated. One plausible explanation is that severe hypoglycemia in people with existing heart disease triggers fatal arrhythmias or other cardiovascular events. Analysis of the trial noted that death from a hypoglycemic event could easily be misclassified as a heart attack at autopsy, since there is no postmortem anatomical marker of hypoglycemia and blood glucose is not always measured at the time of death.14PubMed Central. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials The ACCORD findings reshaped clinical guidelines. They showed that for many patients, especially those who are older or already have cardiovascular disease, the harm from aggressive glucose lowering can outweigh the benefits of preventing chronic hyperglycemic damage.
The Vicious Cycle of Hypoglycemia Unawareness
One of the most dangerous features of hypoglycemia is that it can undermine the body’s ability to detect and respond to future episodes. In type 1 diabetes, repeated exposure to low blood sugar progressively impairs the release of epinephrine and blunts the warning symptoms that tell a person their glucose is falling. This phenomenon is called hypoglycemia-associated autonomic failure, and it creates a vicious cycle: each episode makes the next one more likely and harder to detect.15PubMed Central. Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes
This is not limited to people with diabetes. Research in healthy volunteers showed that just three two-hour periods of induced hypoglycemia over 30 hours significantly blunted the body’s counterregulatory and symptom responses when tested five days later.16PubMed Central. Hypoglycemia-associated autonomic failure in healthy humans: comparison of two vs three periods of hypoglycemia on hypoglycemia-induced counterregulatory and symptom response 5 days later The implication is sobering: the body’s defense against hypoglycemia is fragile. It can be partially disabled by relatively brief exposure to low glucose, and in people with diabetes who experience lows regularly, the defense can erode to the point where the first sign of a dangerous drop is confusion or loss of consciousness rather than the shaking and sweating that would normally serve as a warning.
Hyperglycemia has no equivalent phenomenon. High blood sugar does not blunt your ability to notice that your blood sugar is high. This asymmetry is one of the strongest arguments for why hypoglycemia deserves special vigilance, even in someone whose primary goal is bringing down chronically high readings.
Who Is Most Vulnerable to Each
Age is one of the biggest risk modifiers. Older adults are disproportionately harmed by hypoglycemia for reasons that go beyond the metabolic crisis itself. Severe hypoglycemia more than doubles the risk of falls in people with type 2 diabetes, according to data from a large community-based study.17PubMed Central. Severe Hypoglycemia and Risk of Falls in Type 2 Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study A fall in a person in their 70s or 80s can set off a cascade of hip fractures, hospitalizations, immobility, and decline that has its own mortality risk independent of the blood sugar event that caused it. For older adults, looser blood sugar targets are often the safer choice.
Pregnancy shifts the calculus differently. Hyperglycemia around the time of conception poses a specific risk to fetal development. Elevated HbA1c levels above 5.6% in the periconception period have been linked to an increased risk of congenital heart defects. Preexisting type 2 diabetes raised the odds of these defects by roughly 90%, and this risk persisted even in mothers who maintained normal HbA1c levels with medication, suggesting that some of the teratogenic harm from diabetes operates through pathways beyond glucose control alone.18PubMed Central. Maternal periconception hyperglycemia, preconception diabetes, and risk of major congenital malformations in offspring In pregnancy, hyperglycemia is a more pressing concern than hypoglycemia for the developing baby, though maternal hypoglycemia still carries its own immediate risks.
Hyperglycemia Weakens the Immune System
A dimension of hyperglycemia that often flies under the radar is its effect on infection risk. Even short-term high blood sugar suppresses key parts of the innate immune system. It impairs the ability of neutrophils, the most abundant white blood cells, to migrate toward infections, engulf bacteria, and kill pathogens.19PubMed. The Effect of Short-Term Hyperglycemia on the Innate Immune System This is why surgical wounds heal more slowly in people with uncontrolled diabetes, and why infections like pneumonia and urinary tract infections tend to be more common and more severe in this population.
The effect is especially stark in critical care. Hospital patients who develop stress hyperglycemia, the blood sugar spike that often accompanies severe illness or injury, have a mortality rate roughly three times that of patients with normal blood sugar, even after accounting for diabetes status.20PubMed Central. Hyperglycemia in Critically Ill Patients: Management and Prognosis This finding has driven ICU protocols for glucose management, though the ACCORD-era lesson applies here too: pushing blood sugar down too aggressively in acutely ill patients introduces the competing danger of iatrogenic hypoglycemia.
Glucose Variability as Its Own Problem
Framing the question as “low versus high” misses a third variable that researchers increasingly view as independently harmful: glucose variability, or the degree to which blood sugar swings up and down throughout the day. Laboratory studies have shown that cells exposed to alternating high and normal glucose levels produce more markers of oxidative stress than cells exposed to a constant high glucose level.21BMJ Open Diabetes Research & Care. Glycemic variability and cardiovascular disease in patients with type 2 diabetes In other words, the swinging itself appears to cause damage above and beyond the average glucose level.
This has practical implications. A person whose blood sugar holds steady at 170 mg/dL may actually be doing less vascular damage than someone whose blood sugar ricochets between 60 and 280 throughout the day, even if their average glucose is the same. It also explains why the ACCORD trial’s intensive arm, which likely produced more swings as patients were aggressively treated and then rebounded, may have been harmful for reasons beyond just the hypoglycemic episodes alone. Modern continuous glucose monitors have made glucose variability visible in a way that finger sticks never could, and reducing variability is becoming an explicit treatment target alongside lowering average glucose.
The Fear Factor
There is a psychological dimension that tilts the daily experience of diabetes toward fear of hypoglycemia rather than fear of hyperglycemia. Lows are felt immediately: the trembling, the sweating, the sudden inability to think clearly. Highs are silent. Research has documented that fear of hypoglycemia is a significant source of diabetes distress, and surveys of people with type 1 and type 2 diabetes suggest that even the anticipation of potential glucose prediction technology would moderately improve their anxiety about low blood sugar events.22PubMed Central. Fear of Hypoglycemia and Diabetes Distress: Expected Reduction by Glucose Prediction This fear is rational, but it creates a behavioral asymmetry: people often run their blood sugar higher than ideal as a safety buffer against lows. The long-term cost of that buffer is more exposure to the chronic damage of hyperglycemia.
The Economic and Systemic Toll of Hypoglycemia
Severe hypoglycemia does not just affect the person who experiences it. Emergency room visits and hospitalizations for hypoglycemia cluster in predictable patterns tied to financial cycles. Research on commercially insured Americans found that hypoglycemia-related emergency visits spike at the end of each month, likely because people ration insulin or food as budgets run thin. The estimated cost of this monthly cycle alone was projected at up to $54 million per year in avoidable emergency and hospital expenses among lower-income nonelderly adults.23PubMed Central. The Monthly Cycle of Hypoglycemia: An Observational Claims-based Study of Emergency Room Visits, Hospital Admissions, and Costs in a Commercially Insured Population The finding points to something that biological comparisons between high and low blood sugar can miss: for many people, hypoglycemia is not just a physiological event but a socioeconomic one, driven by medication access, food insecurity, and the daily arithmetic of affording treatment.
Why the Body Tolerates Highs Better Than Lows in the Short Run
From an evolutionary standpoint, the asymmetry makes sense. For most of human history, the relevant threat was starvation, not excess sugar. The body has elaborate hormonal defenses against falling blood sugar, including glucagon, epinephrine, cortisol, and growth hormone, because low glucose was a recurring survival challenge. It has comparatively few acute defenses against high blood sugar, because until modern diets and sedentary lifestyles, sustained hyperglycemia was rare. One hypothesis frames insulin resistance itself as an ancient adaptation to periodic food scarcity, a mechanism that diverts glucose preferentially to the brain at the expense of muscle during lean times.24PubMed Central. Evolutionary origins of insulin resistance: a behavioral switch hypothesis The modern consequence of this evolutionary mismatch is that the body has strong alarm systems for lows but weak ones for highs, which is part of why chronic hyperglycemia can go unnoticed and unaddressed for so long.